Adenoscan
NDC Package 0469-0871-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Adenoscan is a . Marketed by Astellas Pharma Us, Inc., this product is identified by NDC 0469-0871 and is authorized under FDA application NDA020059.

Identification & Billing

NDC Package Code
0469-0871-20
Package Description
10 VIAL in 1 CARTON / 20 mL in 1 VIAL
Product Code
11-Digit Billing Format
00469087120
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Adenoscan
Dosage Form
-

Regulatory & Marketing

Labeler Name
Astellas Pharma Us, Inc.
FDA Application #
NDA020059
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-18-1995
End Marketing Date
06-01-2017
Listing Expiration
06-01-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0469-0871). Click a package code to view its specific billing and regulatory data.

10 VIAL in 1 CARTON / 30 mL in 1 VIAL

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0469-0871-20 identifies a specific commercial package of 10 vial in 1 carton / 20 ml in 1 vial of Adenoscan, labeled by Astellas Pharma Us, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Astellas Pharma Us, Inc. on May 18, 1995. The current certification is valid through June 01, 2017.

How is this Astellas Pharma Us, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00469087120. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0469-0871-20
11-Digit CMS (5-4-2)
00469-0871-20

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.